News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Medicus Pharma Ltd. announces financial results and advancements in clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist. Company highlights important corporate updates and collaborations -
-
COMMUNIQUÉ DE PRESSE
Greenlane Reports Third Quarter 2025 Financial Results
Greenlane Holdings, Inc. reports Q3 2025 financial results and BERA treasury strategy update, shifting to a capital-light model. Emphasis on yield generation and experienced leadership. Raised $110M in capital for BERA acquisitions -
-
COMMUNIQUÉ DE PRESSE
Golden Minerals Reports Third Quarter 2025 Financial Results
Golden Minerals Company (AUMN) reports Q3 2025 financial results and business summary with focus on reducing liabilities, strengthening balance sheet. Exploration updates for Desierto Project and Sand Canyon Project discussed